Skip to content
Back to Guavy Wire
Stocks

Fresenius Medical Care Stock Steadies After JPMorgan Downgrade

Instruments
JPM
Share

Fresenius Medical Care AG's stock price has stabilized after JPMorgan downgraded its rating to Underweight on September 9, 2026. The company's share price had dipped 0.1 percent on Xetra on September 8, 2026, trading at EUR 38.44.

According to finanzen.net, the average analyst target for Fresenius Medical Care stood at EUR 42.02, which is about EUR 3.58 below the current stock price of EUR 38.44.

The company confirmed its 2026 earnings guidance and expects broadly flat revenue development, as reported by Simply Wall St on September 11, 2026.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc